Search

everythinglearnresearchcommunity

for

Search:↓

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

The treatment for alopecia areata with diphenylcyclopropenone was unsuccessful.

Finasteride cream didn't significantly reduce hair more than a placebo, but users felt it helped.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Minoxidil alone is as effective as combining it with PRP for treating female pattern hair loss.

Intermittent iron and nutritional supplements can help reduce hair loss.

Platelet-rich plasma helps hair regrowth and improves quality of life in women with hair loss, but minoxidil may be more effective.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

A new treatment for hair loss was tested and most participants saw their hair loss stop within 2-8 weeks, with up to 50% more hair after 4 months, and no side effects.

Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.

Low-cost videomicroscopes are not as reliable as standard videodermatoscopes for scalp examination due to lower image quality.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Finasteride showed limited hair growth and low patient compliance in treating male pattern baldness.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Bone marrow cells improved tendon health better than platelet-rich plasma.

The placebo microneedle stamp didn't penetrate skin and caused less pain, but blinding was only effective for those with low skin sensitivity.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Herbal solution improves hair diameter and density more than 5% minoxidil for androgenetic alopecia.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Both Unani treatments effectively reduced hair shedding in Telogen Effluvium.